Project Covalence
Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trials is one of their biggest bottlenecks.
Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trials is one of their biggest bottlenecks.
Science remains the only way out of the COVID-19 crisis. Dramatically improving clinical trials, which are usually time-consuming and cost tens to hundreds of millions of dollars, is one of the highest-leverage ways to get out of it faster.
The goal of this project, in collaboration with TrialSpark and Dr. Mark Fishman, is to offer much better clinical trial support to COVID-19 projects than anything that currently exists.
Project Covalence’s platform, powered by TrialSpark, is uniquely optimized to support COVID-19 trials, which are ideally run in community settings or at the patient’s home to reduce the burden placed on hospitals and health systems. Project Covalence is well-positioned to tackle the operational and logistical challenges involved in launching such trials, and supports trial execution, 21 CFR Part 11 compliant remote data collection, telemedicine, biostatistics, sample kits for at-home specimen collection, and protocol writing.
Researchers across academia and industry can leverage this shared infrastructure to rapidly launch their clinical trials. To facilitate coordination between studies, we will also be creating master protocols for platform studies to enable shared control arms and adaptive trial designs.
If you’re interested in getting involved or have a trial that needs support, please get in touch at ProjectCovalence@trialspark.com or visit www.projectcovalence.com.
Twitter Widget Iframe
About the Author
Avneesh is the founder of Permissionless Academy, a platform for young adults to build leverage using AI.
He spent a decade inside the K-12 system building Schoolze (now Schoolze Labs) before concluding that meaningful education reforms have to come from outside it. Today he runs six AI-native and legacy products solo, with agents at the core and no traditional team!
He writes about education, agency, and building leverage in the age of AI!
Related Posts
Super Successful Companies
I spent some time recently thinking about what companies that grow up to be extremely successful do when they are very young. I came up with the following list. It’s from personal experience and I’m sure there are plenty of exceptions. While plenty of non-successful startups do some of these things
Quora
I'm a strong believer in the importance of the internet in helping people to share knowledge and learn from each other. So I’m delighted to share, on behalf of YC Continuity, that we’re investing alongside Collaborative Fund in Quora.
We're in a Bubble
A lot of people have been saying we’re in a tech bubble for quite some time. Someday they’ll be right, but in the meantime, I thought it'd be fun to look back at some articles from the last 10 years:
Idea Generation
The most common question prospective startup founders ask is how to get ideas for startups. The second most common question is if you have any ideas for their startup.